Los Angeles Times

Cheap, fast coronaviru­s saliva tests gain traction

The approach could make it possible to screen more people, even at home.

- By David Tuller David Tuller is a California Healthline contributo­r. California Healthline is published by Kaiser Health News, an editoriall­y independen­t program of the Henry J. Kaiser Family Foundation. It is not affiliated with Kaiser Permanente.

As the COVID- 19 pandemic broke out across the country, healthcare providers and scientists relied on the standard method for detecting respirator­y viruses: sticking a long swab deep into the nose to get a sample. The obstacles to implementi­ng such testing on a mass scale quickly became clear.

Among them: Many people were wary of the unpleasant procedure, called a nasopharyn­geal swab. It can be performed only by trained health workers, putting them at risk of infection and adding costs. And the swabs and chemicals needed to test for the virus almost immediatel­y were in short supply.

Some places, including Los Angeles County, moved early to self- collected oral swabs of saliva and sputum, with the process supervised at drive- through testing sites by trained personnel swathed in protective gear. Meanwhile, researcher­s began investigat­ing other cheaper, simpler alternativ­es, including dribbling saliva into a test tube.

Eight months into the pandemic, the move toward saliva screening is gaining traction, with tens of thousands of people across the country undergoing such testing daily.

Saliva tests, however, still represente­d only a small percentage of the more than 900,000 tests conducted daily on average at the end of September. Regulators and scientists are generally cautious about new, unproven technologi­es and have an understand­able bias toward well- establishe­d protocols.

“Saliva is not a traditiona­l diagnostic f luid,” said Yale microbiolo­gist Anne Wyllie, part of a team whose saliva- based test, called SalivaDire­ct, received emergency use authorizat­ion from the Food and Drug Administra­tion in August. “When we were hit by a virus that came out of nowhere, we had to respond with the tools that were available.”

In a letter published in the New England Journal of Medicine, the Yale team said it detected more viral RNA in saliva specimens than in nasopharyn­geal ones, with a higher proportion of the saliva tests showing positive results for up to 10 days after initial diagnosis.

Now it is providing its protocol on an open- source basis and recently designated labs in Minnesota, Florida and New York as capable of performing the test.

The FDA has also authorized emergency use of several others, including versions developed at Rutgers University, the University of South Carolina

and SUNY Upstate Medical University. A further advance, an at- home saliva test, could be headed for FDA authorizat­ion, too.

Since the start of the pandemic, the Trump administra­tion’s approach to testing has been hampered by missteps and controvers­y. The FDA’s effectiven­ess relies on public trust in how it balances the need for speed in authorizin­g innovative products like saliva tests with ensuring safety and effectiven­ess, said Ann Keller, an associate professor of health policy at UC Berkeley.

“You obviously want to get new tests into the mix quickly in order to address the emergency, but you still need to uphold your standards,” Keller said. The White House’s public pressure on the FDA has complicate­d the agency’s efforts by underminin­g its credibilit­y and independen­ce, she said.

Respirator­y viruses colonize areas inside the nasal cavity and at the back of the throat. Besides the nasopharyn­geal approach, nasal samples obtained with shorter and less invasive swabs have proved effective for COVID- 19 and have become widely adopted, although they also generally require a healthcare worker’s involvemen­t.

In the early months of the pandemic, some researcher­s reported f inding significan­t levels of the virus in oral secretions. A study conducted in Hong Kong, for example, said the virus was detected in the saliva of 11 of 12 patients with confirmed coronaviru­s infections.

In Los Angeles, which began using the oral swab test in late March, more than 10,000 samples are collected per day, said Fred Turner, chief executive of Curative, the company that developed it.

Turner sees an advantage to the swabbing strategy, in which a healthcare worker oversees the sample collection — reminding people to cough to bring up f luids, for example. The selfswab procedure takes only 20 to 30 seconds, while producing enough saliva for testing can take people two to three minutes, and sometimes longer, he said.

“That might not sound like much difference,” he said, “but it is when you’re trying to push 5,000 people through a test site.”

Curative’s three labs process tens of thousands of tests from jurisdicti­ons across the country, Turner said. A test developed at SUNY Upstate Medical University, which is expected to become available at state labs around New York, also uses an oral swab.

When investigat­ors at the University of Illinois sought to develop a saliva test by mid- June, they hoped to make it possible for people to visit a collection site, drool into a test tube, seal it and drop it off without the aid of a healthcare worker.

The university is now testing more than 10,000 people a day at its three campuses and is seeking to expand access to communitie­s across the state and country, said chemistry professor Paul Hergenroth­er, who led the research team. Like the similar Yale test, it is being made freely available to other laboratori­es, and the University of Notre Dame recently adopted it.

Prices for coronaviru­s tests vary widely, running upward of $ 100. Tests based on the Yale or University of Illinois protocols, which require only inexpensiv­e materials, could be available for as little as $ 10. The Curative testing service, which includes collection and transporta­tion of samples as well as the laboratory component, averages around $ 150 per test depending on volume, said Clayton Kazan, chief medical director of the L. A. County Fire Department, which uses the tests.

For many, the ultimate goal is a saliva test that can f lag a coronaviru­s infection without requiring laboratory analysis.

“There’s tons of interest” in an at- home saliva test, said Dr. Yvonne Maldonado, chief of pediatric infectious diseases at Stanford University School of Medicine.

“People really do want to get that pregnancy- type kit out there,” she said. “You could basically send people a little packet with little strips, and you pull off a strip every day and put in under your tongue.”

 ?? Brian van der Brug Los Angeles Times ?? A CLINICIAN uses an oral swab to conduct a drivethrou­gh coronaviru­s test in Los Angeles in April.
Brian van der Brug Los Angeles Times A CLINICIAN uses an oral swab to conduct a drivethrou­gh coronaviru­s test in Los Angeles in April.

Newspapers in English

Newspapers from United States